|View printer-friendly version|
Array BioPharma to Present at the Leerink Swann & Company Cancer Medicines on the Horizon Conference
BOULDER, Colo., Sept. 14 /PRNewswire-FirstCall/ -- Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Robert E. Conway, will speak at the Leerink Swann & Company Cancer Medicines on the Horizon Conference on September 18 in New York City. The public is welcome to participate in the conference through an audio webcast on the Array BioPharma website.
Event: Leerink Swann & Company Cancer Medicines on the Horizon Presenter: Robert E. Conway, Chief Executive Officer, Array BioPharma Date: Monday, September 18, 2006 Time: 10:15 am Eastern Time Location: Le Parker Meridien, New York City Audio Webcast: www.arraybiopharma.com
Additionally, Array's President and Chief Scientific Officer, Kevin Koch, Ph.D., will speak on an expert panel entitled "New Therapy" during the conference.
About Array BioPharma:
Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat life threatening and debilitating diseases. Our proprietary drug development pipeline is focused on the treatment of cancer and inflammatory disease and includes clinical candidates that are designed to regulate therapeutically important targets. In addition, leading pharmaceutical and biotechnology companies collaborate with Array to discover and develop drug candidates across a broad range of therapeutic areas. For more information on Array, please go to www.arraybiopharma.com.
SOURCE Array BioPharma Inc.
CONTACT: Tricia Haugeto of Array BioPharma Inc., +1-303-386-1193,
Web site: http://www.arraybiopharma.com